1

The amounts including restructuring and impairment are reported in accordance with International Financial Reporting Standards (IFRS). The impact of restructuring, impairment and discontinued operations in 2004 is $302 million on net income (2003: $90 million).

2

Adjusted in accordance with recent changes in accounting standards.

3

Constant exchange rates (CER).

4

Net income to shareholders of Syngenta AG.

5

EPS on a fully-diluted basis, excluding restructuring, impairment and discontinued operations, and before a one-off tax credit.

6

After acquisitions of $484 million. Free cash flow.